Clarissa Gabriel Malafronte, APRN

Clarissa Malafronte practices at Bay Dermatology and Cosmetic Surgery P A in Port Richey, Florida.

Clarissa Malafronte's NPI, 1972051241, was assigned on September 15, 2016. Clarissa Malafronte holds Florida license APRN9316294.

Clarissa Malafronte's primary practice is Bay Dermatology and Cosmetic Surgery P A, at 8220 Us-19, Port Richey, FL 34668 in Pasco County. The practice phone is (727) 841-8505.

Clarissa Malafronte's primary practice is Bay Dermatology and Cosmetic Surgery P A in Port Richey, Florida. The medical group on file is Bay Dermatology and Cosmetic Surgery. Dmand AI also links Clarissa Malafronte to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Clarissa Malafronte practices. Vendor and product names are available with a free account.

Nurse practitioner is Clarissa Malafronte's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Clarissa Malafronte is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, eyelid inflammation, hives and itchy rashes among the conditions Clarissa Malafronte treats.

CMS data shows 1,514 Medicare services from Clarissa Malafronte across 11 procedure codes in 2024, for 322 Medicare patients. Medicare paid $51,251 for them. Every service was in an office.

CMS counts 322 Medicare patients who saw Clarissa Malafronte in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Clarissa Malafronte's median patient age at 65, with 61% women.

In 2024, Clarissa Malafronte wrote 736 Medicare Part D claims for 313 patients. 94% of them were for generic drugs. CMS names the drug for 638 of them, across 17 drugs with 11 or more claims each, at $13,633 in total drug cost.

Clarissa Malafronte accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 225 general payments to Clarissa Malafronte from 24 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 96% of the total. UCB, Inc. paid the most, $1,141.